Dataset Information

Global gene expression analysis of breast cancer cell line responses to Topsentinol L Trisulfate or DMSO as the vehicle control

ABSTRACT: We generated a signature for topsentinol L trisulfate in breast cancer cells to predict drug sensitivity in other available datasets. To process the mRNA sequencing data, we used the TCGA mRNA-seq Pipeline. RNA sequencing reads for the treated and control samples were aligned using MapSplice v12_07, quantified using RSEM, and gene counts were normalized using upper quantile normalization. This was the same methodology used to normalize the PANCAN12 TCGA dataset, which we obtained from TCGA fully processed for use in this analysis. To generate a TLT sensitivity signature, we used the DESeq2 package (version 1.4.5) in the Bioconductor framework (version 2.14.0, version 3.1.0 of R) to identify genes that were significantly deregulated (adjusted p < 0.05) between the treated and control samples. One hundred forty-six genes were found to be significantly deregulated, out of which only 131 were found in the TCGA dataset. To use DEseq2, the reads had to be re-mapped using the Rsubread Bioconductor package. We used this package to map the reads to version hg19 of the human genome and to summarize the data to gene-level values. We predicted TLT sensitivity for the PANCAN12 TCGA dataset using the Bayesian binary regression algorithm version 2.0 (BinReg2.0) used as a MATLAB plug-in. We used default parameters, except that our signature used 131 genes and one metagene. The probability output from the binary regression model was subtracted from one so that probabilities closer to one indicated a higher probability of sensitivity to the drug as previously described [29]. Prior to making the predictions, the data were log2 transformed and DWD normalized to reduce biases that can result from differences in batch processing and platforms.

ORGANISM(S): Homo sapiens

PROVIDER: GSE142833 | GEO | 2020/07/30

REPOSITORIES: GEO

ACCESS DATA

Similar Datasets

Project description:Aim: We generated mice lacking Irs2 which mediates signaling pathways from insulin and IL-4 specifically in lyzM Cre expressing cells. We isolated BMDM from control and Irs2LyzM-/- mice and compared their differential gene expression under veihicle, IL-4 and LPS treatment by performing mRNA sequencing studies. Methods: BMDM from control and Irs2LyzM-/- mice were treated for 24 hours with vehicle, IL-4 (10 ng/ml) or LPS (100 ng/ml). RNA integrity was confirmed and concentration measured using a Bioanalyzer. cDNA libraries were created from up to 5 μg total RNA. There were three (Irs2LyzM-/-) and four (control) biological replicates for each group and each biological replicate was divided into eight technical replicates and sequenced on individual lanes on the Illumina HiSeq 2000 (100 bp paired-end read length) at the Sanger Institute. Raw reads from the sequenced RNAseq libraries were mapped with Tophat splice junction aligner (Kim, Pertea et al. 2013), version 2.0.8 against Ensembl mouse genome reference sequence assembly (mm9) and transcript annotations. All parameters were set to default except inner distance between mate pairs (r = 130). Gene-based read counts were then obtained using the HTSeq count module (version 0.5.4p3). Differential expression analysis was performed on the counts data using the DESeq2 Bioconductor package (version 1.16.1). The GSEA preranked tool from GSEA version 2.2.4 was used forGeneset enrichment analysis. Gene ontology enrichment analysis was also performed using the topGo Bioconductor package separately for up and down-regulated genes in the comparisons analysed ( A. Alexa, J. Rahnenfuhrer, topGO: Enrichment Analysis for Gene Ontology. R package version 2.24.0 (2016)). Results: The mRNA seq. results reveal an anti- inflammatory transcriptional profile in LPS-treated Irs2LyzM-/- BMDM compared to control BMDM. Deletion of Irs2 in BMDM under all conditions (vehicle, IL-4 and LPS) manifest alteratons in genes involved in scavenging catecholamines and supporting increased sympathetic innervation.

Project description:ERG and FLI1 are important regulators of angiogenesis, but their role in lymphatic vasculature is less known. The goal of this study was to determine the role of ERG and FLI1 in postnatal lymphangiogenesis and their involvement in SSc lymphatic system defects. IF were used to detect ERG and FLI1 in SSc and healthy controls (HC) skin biopsies. Human lymphatic endothelial cells (LECs) were used in cell culture experiments. Transcriptional and chromatin analysis of ERG or FLI1 silenced LECs was performed using microarrays and ATAC-seq, respectively. Effects of ERG and FLI1 deficiency on in vitro tubulogenesis was examined using Matrigel assay. Erg and Fli1 endothelial specific knockouts (ErgCKO and Fli1CKO) and lymphatic specific knockouts (ProxErgCKO and ProxFli1CKO) were generated to examine vessel regeneration. ERG and FLI1 protein levels were reduced in blood and lymphatic vasculature in SSc skin biopsies. ERG and FLI1 were shown to regulate genes involved in lymphatic vessel specification, including VEGFR3/FLT4, LYVE-1, and PROX1, and this effect was, at least in part, due to chromatin remodeling. ERG/FLT4 pathway regulated in vitro tubulogenesis in LECs. Deficiency of Erg and Fli1 impaired function of blood and lymphatic vessel during wound healing. ERG and FLI1 are essential regulators of blood and lymphatic vessel regeneration. Deficiency of ERG and FLI1 in SSc endothelial cells, may contribute to rarefaction of blood and lymphatic vasculature in SSc patients. Microarray analysis was performed at The Boston University Microarray Core Facility. Affymetrix CEL files were normalized to produce gene-level expression values using the implementation of the Robust Multiarray Average (RMA) in the affy package (version 1.36.1) included within in the Bioconductor software suite (version 2.12) and an Entrez Gene-specific probe set mapping from BrainArray (version 16.0.0). RLE and NUSE quality metrics were computed using the affy PLM Bioconductor package (version 1.34.0). All microarray analyses were performed using the R environment for statistical computing (version 2.15.1).

Dataset Information

Global gene expression analysis of breast cancer cell line responses to Topsentinol L Trisulfate or DMSO as the vehicle control

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure